Mirror syndrome, triple edema or Ballantyne syndrome is a rare disorder affecting pregnant women. It describes the unusual association of fetal and placental hydrops with maternal preeclampsia.[1]
| Mirror syndrome | |
|---|---|
| Other names | Triple edema, Ballantyne syndrome |
| Specialty | OBGYN |
The name "mirror syndrome" refers to the similarity between maternal edema and fetal hydrops. It was first described in 1892 by John William Ballantyne.[2]
Signs and symptoms
editBallantyne syndrome has several characteristics: [citation needed]
- edema, always a key feature
- albuminuria of the mother, usually mild
- preeclampsia, unusual
The fetal symptoms are related to fluid retention, including ascites and polyhydramnios.[3] Fetal hydrops suggests the presence of an important and probably fatal fetal pathology.
It can be associated with parvovirus B19 infection and with twin-to-twin transfusion syndrome.[4]
Causes
editThe etiology may be any of the variety of obstetric problems that range from immunological disorders, including Rh-isoimmunization, to fetal infections, metabolic disorders, and fetal malformations.[5][6][7][8] Ballantyne syndrome can result from the maternal reaction to a fetus that has hemoglobin Barts disease due to inherited double alpha thalassemia trait (alpha thalassemia major) from both parents.[9]
Pathogenesis
editThe etiopathogenetic mechanism of Ballantyne syndrome remains unknown.[citation needed]
Diagnosis
editAlthough the exact etiopathogenetic mechanism of Ballantyne syndrome remains unknown, several authors have reported raised uric acid levels, anemia, and low hematocrit without hemolysis.[1]
Differential diagnosis
editThe problem of distinguishing (or not) between Ballantyne syndrome and preeclampsia is reflected in the diversity of terminology used and in the debate that surrounds the subject. It seems much more likely that an etiology of severe fetal hydrops may cause Ballantyne syndrome when the fetal status greatly worsens and that the syndrome is only a manifestation of the extreme severity of the fetus-placental pathology. Platelet count, aspartate transaminase, alanine transaminase, and haptoglobin are usually unaffected and may be used to distinguish mirror syndrome from HELLP syndrome.[8][10][11][12][13]
Treatment
editIn most cases, Ballantyne syndrome causes fetal or neonatal death. In contrast, maternal involvement is limited at the most to preeclampsia. [medical citation needed]
References
edit- ^ a b Paternoster DM, Manganelli F, Minucci D, Nanhornguè KN, Memmo A, Bertoldini M, Nicolini U (2006). "Ballantyne Syndrome: a Case Report". Fetal Diagnosis and Therapy. 21 (1): 92–5. doi:10.1159/000089056. PMID 16354984. S2CID 36608058.
- ^ "Ballantyne's syndrome".
- ^ Vidaeff AC, Pschirrer ER, Mastrobattista JM, Gilstrap LC, Ramin SM (2002). "Mirror syndrome. A case report". The Journal of Reproductive Medicine. 47 (9): 770–4. PMID 12380459.
- ^ Chang YL, Chao AS, Hsu JJ, Chang SD, Soong YK (2007). "Selective fetocide reversed mirror syndrome in a dichorionic triplet pregnancy with severe twin-twin transfusion syndrome: a case report". Fetal Diagn. Ther. 22 (6): 428–30. doi:10.1159/000106348. PMID 17652930. S2CID 21536375.
- ^ Balakumar K (2003). "Antenatal diagnosis of vein of Galen aneurysm: case report". Indian Journal of Radiology and Imaging. 13 (1): 91–2. Archived from the original on 2018-05-27. Retrieved 2011-03-31.
- ^ Carbillon L, Oury JF, Guerin JM, Azancot A, Blot P (1997). "Clinical biological features of Ballantyne syndrome and the role of placental hydrops". Obstetrical & Gynecological Survey. 52 (5): 310–4. doi:10.1097/00006254-199705000-00023. PMID 9140132.
- ^ Machado LE, Osborne NG, Bonilla-Musoles F (2002). "Two-dimensional and three-dimensional ultrasound of fetal (baby) anasarca: the glass baby". Journal of Perinatal Medicine. 30 (1): 105–10. doi:10.1515/JPM.2002.013. PMID 11933650. S2CID 26606491.
- ^ a b Van Selm M, Kanhai HH, Gravenhorst JB (1991). "Maternal hydrops syndrome: a review". Obstetrical & Gynecological Survey. 46 (12): 785–8. doi:10.1097/00006254-199112000-00001. PMID 1780115.
- ^ "Archived copy" (PDF). sogc.org. Archived from the original (PDF) on 27 August 2014. Retrieved 22 May 2022.
{{cite web}}: CS1 maint: archived copy as title (link) - ^ Pirhonen JP, Hartgil TW (2004). "Spontaneous reversal of mirror syndrome in a twin pregnancy after a single fetal death". European Journal of Obstetrics & Gynecology and Reproductive Biology. 116 (1): 106–7. doi:10.1016/j.ejogrb.2003.12.011. PMID 15294378.
- ^ Gherman RB, Incerpi MH, Wing DA, Goodwin TM (1998). "Ballantyne syndrome: is placental ischemia the etiology?". Journal of Maternal-Fetal Medicine. 7 (5): 227–9. doi:10.1002/(SICI)1520-6661(199809/10)7:5<227::AID-MFM3>3.0.CO;2-I. PMID 9775990.
- ^ Heyborne KD, Chism DM (2000). "Reversal of Ballantyne syndrome by selective second-trimester fetal termination. A case report". Journal of Reproductive Medicine. 45 (4): 360–2. PMID 10804498.
- ^ Midgley DY, Harding K (2000). "The mirror syndrome". European Journal of Obstetrics & Gynecology and Reproductive Biology. 88 (2): 201–2. doi:10.1016/S0301-2115(99)00147-5. PMID 10690681.